ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
65,064.69
0.31%
S&P 500
5,667.20
0.64%
Dow Jones
40,954.48
1.85%
US Dollar vs Yen
158.329
0.12%
Brent Oil
83.23
-1.32%
Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. USOTC
  6. RespireRx Pharmaceuticals Inc (PK) (RSPI)

  7. RespireRx Pharmaceuticals Inc (PK) (RSPI) ニュース

RSPI

RespireRx Pharmaceuticals (PK) (RSPI)

RespireRx Pharmaceuticals Inc (PK)
から:
次の項目別のソート:
 Showing the most relevant articles for your search:USOTC:RSPI
日付受信時刻ニュースソース見出しコード企業名
2020/05/0706 : 09Edgar (US Regulatory)Current Report Filing (8-k)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2020/04/2205 : 51Edgar (US Regulatory)Current Report Filing (8-k)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2020/04/1505 : 08Edgar (US Regulatory)Annual Report (10-k)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2020/04/1105 : 16Edgar (US Regulatory)Information Statement - All Other (definitive) (def 14c)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2020/03/3105 : 16Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2020/03/2706 : 21Edgar (US Regulatory)Current Report Filing (8-k)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2020/03/2505 : 49Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2020/03/2505 : 21Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2020/03/2502 : 51Edgar (US Regulatory)Proxy Statement - Other Information (preliminary) (pre 14c)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2020/03/2004 : 08Edgar (US Regulatory)Current Report Filing (8-k)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2020/03/1005 : 23Edgar (US Regulatory)Current Report Filing (8-k)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2020/03/0605 : 25Edgar (US Regulatory)Current Report Filing (8-k)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2020/03/0423 : 06Edgar (US Regulatory)Current Report Filing (8-k)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2020/02/1223 : 21Edgar (US Regulatory)Current Report Filing (8-k)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2020/02/0323 : 11Edgar (US Regulatory)Current Report Filing (8-k)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2019/12/3023 : 17Edgar (US Regulatory)Current Report Filing (8-k)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2019/12/1906 : 31Edgar (US Regulatory)Current Report Filing (8-k)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2019/11/2007 : 05Edgar (US Regulatory)Quarterly Report (10-q)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2019/11/1506 : 35Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2019/11/0605 : 01Edgar (US Regulatory)Current Report Filing (8-k)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2019/10/2906 : 22Edgar (US Regulatory)Current Report Filing (8-k)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2019/09/1006 : 16Edgar (US Regulatory)Current Report Filing (8-k)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2019/08/2805 : 34Edgar (US Regulatory)Current Report Filing (8-k)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2019/08/1505 : 33Edgar (US Regulatory)Quarterly Report (10-q)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2019/05/2405 : 47Edgar (US Regulatory)Current Report Filing (8-k)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2019/05/2105 : 09Edgar (US Regulatory)Quarterly Report (10-q)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2019/05/1606 : 02Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2019/05/0105 : 10Edgar (US Regulatory)Current Report Filing (8-k)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2019/04/1705 : 41Edgar (US Regulatory)Annual Report (10-k)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2019/04/0205 : 08Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
 Showing the most relevant articles for your search:USOTC:RSPI

最近閲覧した銘柄

NYSE
BAC
Bank of America
USOTC
BNPQY
BNP Paribas (QX)
AMEX
XLE
Energy Select Sector SPDR
NASDAQ
NVDA
NVIDIA
AMEX
SPY
SPDR S&P 500
NYSE
DIS
Walt Disney
FX
USDEUR
US Dollar vs Euro
USI
USTECH100
US Tech 100
NYSE
VZ
Verizon Communications
NASDAQ
AMZN
Amazon.com
NYSE
XOM
Exxon Mobil
CCOM
US500
US 500
USOTC
BASFY
BASF (QX)
NYSE
MCD
McDonalds
PM
XAUUSD
Gold vs US Dollar
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有